Literature DB >> 31013217

Survival of Patients with Primary Cardiac Tumors in an 11-Year Single Center Study.

Aizezi Maimaitiaili1, Wei-Min Zhang1, Yong-Zhong Guo1, Doshahar Elmaik1, Nian-He Tang1, Zong-Gang Zhang1.   

Abstract

BACKGROUND: Primary cardiac tumors are rare, but few studies have examined the relationship between risk factors and the prognosis. The aim of this study was to provide a survival analysis and risk factors for mortality in patients with primary cardiac tumors.
METHODS: We retrospectively enrolled 71 patients diagnosed with primary cardiac tumors from June 2006 to November 2017 in our hospital. Patients' population characteristics, treatment information, pathology, and follow-up data were obtained and analyzed.
RESULTS: Of the 71 patients, 60 cases were benign, and 11 cases were malignant. Sex, age, New York Heart Association classification, the percentage of peripheral embolism, and surgery had no significant difference between benign and malignant groups (P >.05), but the percentage of arrhythmia, leg edema, and mortality rate was higher in the malignant tumor group than in the benign tumor group (P <.05). Compared with the benign tumor group, the percentage of biatrial lesions in the malignant tumor group was significantly higher (P <.05). Moreover, Independent risk factors included the treatment choice, pathology type, and number of tumor lesions (P <.05).
CONCLUSION: Our study suggests that conservative therapy, malignant cardiac tumor, and biatrial tumor lesion are independent risk factors for poor prognosis. 2019 Forum Multimedia Publishing, LLC

Entities:  

Mesh:

Year:  2019        PMID: 31013217     DOI: 10.1532/hsf.2271

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  1 in total

1.  Diagnosis and survival analyses of patients with space-occupying cardiac lesions: a 10-year retrospective single-center study.

Authors:  Lei Liu; Aijuan Fang; Siyuan Cheng; Guanjun Guo; Suming Zhang; Xiaofang Chen; Jun Pan; Bugao Sun; Jing Yao
Journal:  Quant Imaging Med Surg       Date:  2022-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.